Zobrazeno 1 - 10
of 385
pro vyhledávání: '"Chuanyong Guo"'
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 167, Iss , Pp 115538- (2023)
Tripartite motif (TRIM) family is assigned to RING-finger-containing ligases harboring the largest number of proteins in E3 ubiquitin ligating enzymes. E3 ubiquitin ligases target the specific substrate for proteasomal degradation via the ubiquitin
Externí odkaz:
https://doaj.org/article/63746bb00dae407ebb4ca6e7303f2b4a
Autor:
Yan Li, Wenjuan Yang, Yuanyuan Zheng, Weiqi Dai, Jie Ji, Liwei Wu, Ziqi Cheng, Jie Zhang, Jingjing Li, Xuanfu Xu, Jianye Wu, Mingwei Yang, Jiao Feng, Chuanyong Guo
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-19 (2023)
Abstract Background Sorafenib resistance is a key impediment to successful treatment of patients with advanced hepatocellular carcinoma (HCC) and recent studies have reported reversal of drug resistance by targeting ferroptosis. The present study aim
Externí odkaz:
https://doaj.org/article/1d317e57a4e94150b8a72d58c3a8d94c
Autor:
Yuanyuan Zheng, Wenjuan Yang, Yewei Jia, Jie Ji, Liwei Wu, Jiao Feng, Yan Li, Ziqi Cheng, Jie Zhang, Jingjing Li, Weiqi Dai, Xuanfu Xu, Jianye Wu, Yingqun Zhou, Chuanyong Guo
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: Colorectal cancer (CRC) is the fourth most common cancer worldwide, with high morbidity and mortality rates. In recent years, high-fat diet has been shown to increase CRC morbidity, highlighting the possibility of the application of hyp
Externí odkaz:
https://doaj.org/article/5a899735b2084d5e8d4e7b6952e82ef1
Autor:
Yuanyuan Zheng, Yan Li, Jiao Feng, Jingjing Li, Jie Ji, Liwei Wu, Qiang Yu, Weiqi Dai, Jianye Wu, Yingqun Zhou, Chuanyong Guo
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-16 (2021)
Abstract Primary liver cancer (PLC) is a common malignancy with high morbidity and mortality. Poor prognosis and easy recurrence on PLC patients calls for optimizations of the current conventional treatments and the exploration of novel therapeutic s
Externí odkaz:
https://doaj.org/article/0d2feab10694464b8079b8ba5a8eaf8b
Autor:
Yan Li, Yuanyuan Zheng, Liwei Wu, Jingjing Li, Jie Ji, Qiang Yu, Weiqi Dai, Jiao Feng, Jianye Wu, Chuanyong Guo
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-17 (2021)
Abstract The conventional method used to obtain a tumor biopsy for hepatocellular carcinoma (HCC) is invasive and does not evaluate dynamic cancer progression or assess tumor heterogeneity. It is thus imperative to create a novel non-invasive diagnos
Externí odkaz:
https://doaj.org/article/bfe6dcbf0ce94ba19099c2c29dd5cdb9
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 39, Iss 1, Pp 1-19 (2020)
Abstract Liver cancer has become the sixth most diagnosed cancer and the fourth leading cause of cancer death worldwide. Hepatocellular carcinoma (HCC) is responsible for up to 75–85% of primary liver cancers, and sorafenib is the first targeted dr
Externí odkaz:
https://doaj.org/article/fb88ec0651054b46a68e9d06b4753c0c
Autor:
Jiao Feng, Weiqi Dai, Yuqing Mao, Liwei Wu, Jingjing Li, Kan Chen, Qiang Yu, Rui Kong, Sainan Li, Jie Zhang, Jie Ji, Jianye Wu, Wenhui Mo, Xuanfu Xu, Chuanyong Guo
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 39, Iss 1, Pp 1-18 (2020)
Abstract Background Hepatocellular carcinoma (HCC) is a common primary malignant tumor which usually progresses to an advanced stage because of late diagnosis. Sorafenib (Sora) is a first line medicine for advanced stage HCC; however, it has been fac
Externí odkaz:
https://doaj.org/article/aaf42ed1df9543eba59fbd4288cc2c9b
Autor:
Jiameng Ding, null WenjuanYang, Yuhui Jiang, Jie Ji, Jie Zhang, Liwei Wu, Jiao Feng, Yuanyuan Zheng, Yan Li, Ziqi Cheng, Qiang Yu, Jianye Wu, Jingjing Li, Kan Chen, Chuanyong Guo
Publikováno v:
Mediators of Inflammation, Vol 2022 (2022)
Hepatic ischemia/reperfusion injury (HIRI) is a common complication of liver surgery requiring hepatic disconnection, such as hepatectomy and liver transplantation. The aim of this study was to investigate the effects of cordycepin on HIRI and to elu
Externí odkaz:
https://doaj.org/article/cf2cb88ab0604f2c9b166dd5362a52d9
Autor:
Yuhui Jiang, Wenjuan Yang, Jiameng Ding, Jie Ji, Liwei Wu, Yuanyuan Zheng, Yan Li, Ziqi Cheng, Jie Zhang, Qiang Yu, Jiao Feng, Jingjing Li, Jianye Wu, Yingqun Zhou, Chuanyong Guo
Publikováno v:
PPAR Research, Vol 2022 (2022)
Hepatic ischemia-reperfusion (IR) injury is a clinically significant process that frequently occurs in liver transplantation, partial hepatectomy, and hemorrhagic shock. The aim of this study was to explore the effectiveness of luteolin in hepatic IR
Externí odkaz:
https://doaj.org/article/e94db8358e7e468bbc538c04f8931728
Autor:
Liwei Wu, Jingjing Li, Tong Liu, Sainan Li, Jiao Feng, Qiang Yu, Jie Zhang, Jiaojiao Chen, Yuting Zhou, Jie Ji, Kan Chen, Yuqing Mao, Fan Wang, Weiqi Dai, Xiaoming Fan, Jianye Wu, Chuanyong Guo
Publikováno v:
Cancer Medicine, Vol 8, Iss 10, Pp 4806-4820 (2019)
Abstract Objective Hepatocellular carcinima is one of the most common tumors in clinic and also one of the leading causes of death from cancer worldwide. Quercetin shows significant effects on blocking the development of various cancers. Methods We u
Externí odkaz:
https://doaj.org/article/59ebed8c298f474ba78333128404c39b